Education
About Us
Working with TipRanks
Follow Us
Aequus Pharmaceuticals Inc (TSE:AQS)
:AQS
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 584.24K | C$ 254.90K | C$ 1.38M | C$ 2.71M | C$ 2.59M |
| Gross Profit | C$ 199.97K | C$ 143.66K | C$ 1.15M | C$ 2.69M | C$ 2.59M |
| Operating Income | C$ -2.13M | C$ -2.82M | C$ -2.50M | C$ -1.35M | C$ -521.57K |
| EBITDA | C$ -1.79M | C$ -2.68M | C$ -2.87M | C$ -1.23M | C$ -314.80K |
| Net Income | C$ -2.18M | C$ -2.96M | C$ -3.21M | C$ -1.81M | C$ -1.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 50.24K | C$ 170.20K | C$ 294.67K | C$ 2.39M | C$ 1.72M |
| Total Assets | C$ 800.28K | C$ 1.09M | C$ 1.69M | C$ 4.35M | C$ 3.13M |
| Total Debt | C$ 6.61M | C$ 5.06M | C$ 782.92K | C$ 2.18M | C$ 2.32M |
| Net Debt | C$ 6.56M | C$ 4.89M | C$ 533.10K | C$ -211.31K | C$ 604.74K |
| Total Liabilities | C$ 7.26M | C$ 5.38M | C$ 3.07M | C$ 2.56M | C$ 2.56M |
| Stockholders' Equity | C$ -6.45M | C$ -4.29M | C$ -1.38M | C$ 1.79M | C$ 573.95K |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.66M | C$ -2.29M | C$ -1.95M | C$ -1.18M | C$ -817.23K |
| Operating Cash Flow | C$ -1.66M | C$ -2.29M | C$ -1.95M | C$ -1.17M | C$ -804.91K |
| Investing Cash Flow | C$ 44.85K | C$ 0.00 | C$ 0.00 | C$ -507.96K | C$ -12.32K |
| Financing Cash Flow | C$ 1.49M | C$ 2.21M | C$ -189.19K | C$ 2.40M | C$ 2.05M |
Aequus Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.